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Abstract
Background:  Succinylcholine  is  commonly  used  to  achieve  profound  neuromuscular  blockade  of
rapid onset  and  short  duration.
Objective:  The  present  study  compared  the  efﬁcacy  of  pregabalin  for  prevention  of
succinylcholine-induced  fasciculation  and  myalgia.
Design:  Prospective,  randomized,  placebo  controlled,  double  blinded  study.
Materials  and  methods:  Patients  of  both  genders  undergoing  elective  spine  surgery  were  ran-
domly assigned  to  two  groups.  Patients  in  Group  P  (pregabalin  group)  received  150  mg  of
pregabalin  orally  1  h  prior  to  induction  of  anesthesia  with  sips  of  water  and  patients  in  Group
C (control  group)  received  placebo.  Anesthesia  was  induced  with  fentanyl  1.5  mcg/kg,  propo-
fol 1.5--2.0  mg/kg  followed  by  succinylcholine  1.5  mg/kg.  The  intensity  of  fasciculations  was
assessed by  an  observer  blinded  to  the  group  allotment  of  the  patient  on  a  4-point  scale.  A
blinded observer  recorded  postoperative  myalgia  grade  after  24  h  of  surgery.  Patients  were
provided patient-controlled  analgesia  with  fentanyl  for  postoperative  pain  relief.
Results: Demographic  data  of  both  groups  were  comparable  (p  >  0.05).  The  incidence  of  muscle
fasciculation’s  was  not  signiﬁcant  between  two  groups  (p  =  0.707),  while  more  patients  in  group
C had  moderate  to  severe  fasciculation’s  compared  to  group  P  (p  =  0.028).  The  incidence  and
severity of  myalgia  were  signiﬁcantly  lower  in  group  P  (p  <  0.05).
Conclusion:  Pregabalin  150  mg  prevents  succinylcholine-induced  fasciculations  and  myalgia  and
also decreases  the  fentanyl  consumption  in  elective  sine  surgery.a  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights© 2014  Sociedade  Brasileir
reserved.∗ Corresponding author.
E-mail: drvinit75@gmail.com (V.K. Srivastava).
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Uso  proﬁlático  de  pregabalina  para  prevenc¸ão  de  mialgia  e  fasciculac¸ão  induzidas
por  succinilcolina:  estudo  randômico,  duplo-cego  e  controlado  por  placebo
Resumo
Justiﬁcativa:  A  succinilcolina  é  comumente  usada  para  atingir  um  bloqueio  neuromuscular
profundo, de  início  rápido  e  de  curta  durac¸ão.
Objetivo:  O  presente  estudo  comparou  a  eﬁcácia  de  pregabalina  na  prevenc¸ão  de  mialgia  e
fasciculac¸ão induzidas  por  succinilcolina.
Desenho:  Estudo  prospectivo,  randômico,  duplo-cego  e  controlado  por  placeboo.
Materiais  e  métodos:  Pacientes  de  ambos  os  sexos  submetidos  à  cirurgia  eletiva  de  coluna
foram aleatoriamente  divididos  em  dois  grupos.  Os  pacientes  do  Grupo  P  (pregabalina)  rece-
beram 150  mg  de  pregabalina  oral  1  hora  antes  da  induc¸ão  da  anestesia  e  os  pacientes  do  Grupo
C (controle)  receberam  placebo.  A  anestesia  foi  induzida  com  fentanil  (1,5  mcg/kg)  e  propofol
(1,5-2,0 mg/kg),  seguidos  de  succinilcolina  1,5  mg/kg.  A  intensidade  da  fasciculac¸ão  foi  avali-
ada por  um  observador,  cego  para  a  alocac¸ão  dos  grupos,  usando  uma  escala  de  4  pontos.  Um
observador  cego  registrou  o  grau  pós-operatório  de  mialgia  após  24  horas  de  cirurgia.  Para  o
alívio da  dor  no  pós-operatório,  fentanil  foi  usado  em  sistema  de  analgesia  controlada  pelo
paciente.
Resultados:  Os  dados  demográﬁcos  de  ambos  os  grupos  eram  comparáveis  (p  >  0,05).  A  incidên-
cia de  fasciculac¸ão  muscular  não  foi  signiﬁcativa  entre  os  dois  grupos  (p  =  0,707),  enquanto  mais
pacientes  do  Grupo  C  apresentaram  fasciculac¸ão  de  moderada  a  grave  em  relac¸ão  ao  Grupo  P
(p =  0,028).  A  incidência  ea  gravidade  de  mialgia  foram  signiﬁcativamente  menores  no  grupo  P
(p <  0,05).
Conclusão:  Pregabalina  (150  mg)  previne  mialgia  e  fasciculac¸ão  induzidas  por  succinilcolina,
além de  diminui  o  consumo  de  fentanil  em  cirurgia  eletiva  de  coluna.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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uccinylcholine  is  a  short  acting  depolarizing  muscle  relax-
nt  with  rapid  onset  and  short  duration  of  action.  Its  use  is
ssociated  with  a  number  of  side  effects  like  fasciculation,
ostoperative  myalgia,  increased  serum  levels  of  creatine
inase  and  potassium,  malignant  hyperthermia,  myoglobin-
ria,  raised  intraocular  pressure  and  intracranial  pressure
recluding  its  routine  use.1,2 Fasciculations  are  relatively
enign  side  effects  of  its  use;  most  anesthesiologists  pre-
er  to  prevent  them  due  to  a  possible  association  between
asciculations  and  postoperative  myalgia.
Different  pre-treatment  modalities  have  been  attempted
o  reduce  the  incidence  and  severity  of  fasciculations  and
yalgia.  This  includes  precurarization  with  a  small
ose  of  non-depolarizing  muscle  relaxant,3 pre  succinyl-
holine  use  of  lidocaine,4 calcium  gluconate,5 magnesium
ulphate,6 nonsteroidal  anti-inﬂammatory  drugs  (NSAIDs),7
exmedetomidine,8 benzodiazepines,4 remifentanil,9
henytoin10 or  ketorolac.11 The  efﬁcacy  of  each  is  variable.
Pregabalin  and  its  predecessor,  gabapentin,  are  analogs
f  the  inhibitory  neurotransmitter  gammaaminobutyric  acid
GABA).  As  gabapentin12 has  been  found  to  prevent  succinyl-
holine  induced  fasciculation  and  myalgia,  pregabalin  may
e  an  alternative  of  this  with  better  results.
With  this  aim,  this  randomized,  double-blinded,  placebo-
ontrolled  study  was  instituted  to  investigate  whether  use
f  preoperative  pregabalin  administration  has  any  effects
n  succinylcholine-induced  fasciculation’s  and  myalgia  in
P
wubjects  undergoing  microdiscectomy  under  general  anes-
hesia.
aterials and methods
his  prospective,  randomized,  placebo-controlled  study  was
onducted  after  approval  from  the  Institutional  Ethics  Com-
ittee  and  written  informed  consent  from  the  patients
ndergoing  elective  spine  surgery  under  general  anesthe-
ia.  The  study  was  registered  at  Clinical  Trials.gov  (Ref.:
TRI/2013/08/003925).
Sixty-four  patients,  aged  20--60  years,  either  sex,  ASA
hysical  status  I  or  II,  scheduled  for  elective  spine  surgery
ere  included  in  the  study.  Patients  with  a  history  of
eizure  disorders,  preoperative  ingestion  of  pregabalin  or
abapentin,  hyperkalemia,  systemic  illness  like  hyperten-
ion,  diabetes,  impaired  kidney  or  liver  functions,  increased
ntracranial  and  intraocular  pressure,  pregnant  or  breast-
eeding  females  and  patients  with  known  sensitivity  to
regabalin  were  excluded  from  the  study.  The  patients  were
andomly  allocated  to  two  equal  groups  with  the  help  of  a
omputer  generated  table  of  random  numbers  to  receive
ollowing  drugs.
roup  P  (pregabalin  group)atients  received  pregabalin  150  mg  orally  with  sips  of
ater,  1  h  before  the  induction  of  anesthesia.
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Table  1  Demographic  data.
Group  C  (n  =  32)  Group  P  (n  =  32)  p-Value
Mean  age  (yrs) 47.03  ±  10.12 48.87  ±  7.97  0.4212
Male/female  21/11  19/13  0.796
Weight (kg)  61.19  ±  8.30  63.28  ±  10.06  0.367
Spine surgery
Cervical/thoracic/lumbar  12/1/19  10/0/22  0.496
Duration of  surgery  (min)  138.69  ±  33.43  133.44  ±  39.42  0.5676
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Group  C  (control  group)
Patients  received  similar  looking  placebo  tablet  orally  with
sips  of  water,  1  h  before  the  induction  of  anesthesia.
All  the  patients  were  premedicated  with  oral  lorazepam
2  mg  and  ranitidine  150  mg  night  before,  and  2  h  prior  to
surgery.  The  study  drugs  were  given  to  the  nurse  atten-
dant  in  identical  envelopes  marked  P  and  C.  The  nature  of
the  medications  was  not  known  to  the  nurse  attendant  who
administered  the  drugs  as  per  instructions.
In  the  operating  room,  after  establishing  the  basic  mon-
itoring  anesthesia  was  induced  by  injection  (inj.)  fentanyl
1.5  mcg/kg,  propofol  1.5--2.0  mg/kg  and  succinylcholine
1.5  mg/kg  body  weight.  The  intensity  of  fasciculation’s  was
assessed  by  an  observer  blinded  to  the  group  allotment  of
the  patient  on  a  4-point  scale  as  Absent  (0);  Mild  --  ﬁne  fas-
ciculation’s  at  the  eyes,  neck,  face  or  ﬁngers  without  limb
movement  (1);  Moderate  --  fasciculation’s  occurring  bilat-
erally  or  obvious  limb  movement  (2);  Severe  --  widespread,
sustained  fasciculation’s  (3).
The  patients  were  intubated  with  an  appropriate  sized
cuffed  endotracheal  tube  after  assessing  complete  muscular
relaxation  by  single  twitch  neuromuscular  monitoring.  Anes-
thesia  was  maintained  with  oxygen:nitrous  oxide  (O2:N2O;
33:66)  and  sevoﬂurane.  Vecuronium  bromide  0.1  mg/kg  was
given  after  endotracheal  intubation.  Intermittent  doses  of
fentanyl  and  vecuronium  bromide  were  administered  during
surgery  as  indicated.  After  completion  of  surgery,  neuromus-
cular  blockade  was  reversed  and  patients  shifted  to  post
anesthesia  care  unit  (PACU).
In  PACU  patients  received  postoperative  analgesia  with
fentanyl  (5  mcg/mL)  through  patient  controlled  analgesia
(PCA)  pump  (Smith  Medical  ASD,  Inc.,  USA).  The  total
fentanyl  requirement  in  the  ﬁrst  24  h  was  recorded.  Any
complications  like  postoperative  nausea,  vomiting,  dizzi-
ness,  somnolence,  vertigo,  confusion,  blurred  vision  and  dry
mouth  were  also  being  recorded  and  managed  accordingly.
The  incidence  and  severity  of  myalgia  were  assessed  by
a  blinded  observer  24  h  after  surgical  intervention,  utilizing
a  four-point  rating  scale  and  graded  as:  absence  of  muscle
pain  (0);  muscle  stiffness,  limited  to  one  area  only  (1);  mus-
cle  pain  or  stiffness  noticed  spontaneously  by  the  patient,
which  may  require  analgesic  therapy  (2);  and  generalized,
severe  or  incapacitating  discomfort  (3).The  postoperative  sedation  level  was  assessed  by  the
Ramsay  sedation  score  which  consists  of  the  following  six
grades:  anxious  (1),  cooperative  and  tranquil  (2),  respon-
ding  to  commands  only  (3),  brisk  response  to  light  glabellar
o
(
c
2.
ap  (4),  sluggish  response  to  light  glabellar  tap  (5),  and  no
esponse  to  light  glabellar  tap  (6).
Sample  size  calculation  was  based  on  the  pilot  study,
here  the  incidence  of  fasciculation  was  found  to  be  96%.
e  aimed  to  decrease  the  incidence  by  50%  with  pregabalin
re-treatment.  With  a  power  of  80%  and  type  I  error  of  5%,
e  calculated  that  30  subjects  were  required  per  group.  To
ake  care  of  any  dropouts,  we  enrolled  32  patients  in  each
roup.
Statistical  analysis  was  performed  using  the  Graph  pad
rism  6.0  statistical  software.  The  demographic  data  were
nalyzed  by  Student  t-test.  Male  and  female  data  were  ana-
yzed  with  the  Chi  square  test.  The  consumption  of  fentanyl
nd  sedation  in  groups  were  analyzed  by  using  Student  t-
est.  The  incidence  and  severity  of  fasciculation  and  myalgia
ere  analyzed  using  Fisher’s  exact  test.  A  p-value  of  <0.05
as  considered  statistically  signiﬁcant.
esults
eventy-two  patients  were  assessed  for  eligibility  between
eptember  2013  and  February  2014.  Sixty-four  patients  were
ncluded  in  the  study  after  randomization  and  61  patients
95.3%)  completed  the  study  (Fig.  1).  Eight  patients  were
ot  included  in  this  study  on  account  of  patient’s  refusal
2  patients),  preoperative  history  of  analgesic  consump-
ion  (6  patients).  Three  patients  were  excluded  from  the
tudy  following  initial  randomization  on  account  of  need
f  postoperative  ventilator  support  (2  patients)  and  PCA
ump  failure  (1  patient);  their  data  has  been  included  in
he  comparison  of  demographic  proﬁle,  however,  they  were
ot  subjected  to  further  statistical  analysis  (Fig.  1).
There  were  no  signiﬁcant  differences  between  the  two
roups  with  respect  to  age,  gender,  body  weight,  type  and
uration  of  surgery  (p  >  0.05)  (Table  1).
The  overall  incidence  of  muscle  fasciculation’s  was  83.9%
n  group  P and  90%  in  group  C  (p  =  0.707)  (Table  2).  The  grades
f  muscle  fasciculation’s  observed  were  mild  (57.7%),  mod-
rate  (34.6%)  and  severe  (7.7%)  in  Group  P,  while  22.2%,
9.2%,  and  18.5%  respectively  in  Group  C.  More  patients  in
roup  C  had  moderate  to  severe  fasciculation’s  compared
o  Group  P  (p  =  0.028).
Six  (19.3%)  patients  of  group  P  and  14  (46.7%)  patients
f  group  C  had  postoperative  myalgia  after  24  h  (p  =  0.03)
Table  3).  The  severity  of  myalgia  was  less  in  the  group  P
ompared  to  group  C  (5  and  1  vs.  10  and  4  of  Grade  1  and
 myalgia  respectively).  None  of  the  patients  complained
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8 patients excluded:
Patient refusal (n=2)
Analgesic consumption
(n=6)
Enrollment n=64
Group P n=32
Group P (n=31)
Drop outs (n=1)
Analyzed (n=31)Analysis
Follow up
Allocation
Analyzed (n=30)
Group C (n=30)
Drop outs (n=2)
Group C n=32
Assessed for eligibility 
n=72
Figure  1  Stu
Table  2  The  incidence  and  severity  of  fasciculations.
Group  C  (n  =  30)  Group  P  (n  =  31)  p-Value
Fasciculations
No  3  (10%)  5  (16.1%)
Yes 27  (90%)  26  (83.9%)  0.707
Severity  of  fasciculations
Mild  6  (22.2%)  15  (57.7%)
Moderate  16  (59.2%)  9  (34.6%)  0.028
Severe 5  (18.5%)  2  (7.7%)
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f  myalgia  of  grade  3  in  any  study  groups.  No  association
etween  the  incidence/grade  of  fasciculation’s  and  myalgia
as  demonstrated.
The  consumption  of  fentanyl  in  the  ﬁrst  24  h  was  sig-
iﬁcantly  less  in  the  group  P  compared  to  the  group  C
674.03  ±  137.84  mcg  vs.  1002.67  ±  214.43  mcg)  (p  <  0.001).
edation  score  was  signiﬁcantly  higher  in  group  P  (p  =  0.004)
Table  4).
Table  3  The  incidence  and  severity  of  myalgia.
Group  C  (n  =  30)  Group  P  (n  =  31)  p-Value
Myalgia
No  16  (53.3%)  25  (80.7%)
Yes 14  (46.7%)  6  (19.3%)  0.030
Severity  of  myalgia
Mild  10  (71.4%)  5  (83.3%)
Moderate  4  (28.6%)  1  (16.7%)  0.020
Severe 0  0
Data are presented as numbers with percentage.
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iscussion
uccinylcholine  is  the  best  drug  for  rapidly  providing  ideal
onditions  for  short  procedures  requiring  endotracheal  intu-
ation.  Unfortunately,  its  use  is  associated  with  muscular
asciculation’s  and  postoperative  myalgia.
Fasciculation  produced  by  succinylcholine  have  been
ttributed  to  a  prejunctional  depolarizing  action  of  suc-
inylcholine,  resulting  in  repetitive  ﬁring  of  the  motor
erve  terminals  and  antidromic  discharges  that  mani-
ests  as  an  uncoordinated  muscle  contractions.13 Various
rugs  have  been  found  to  inﬂuence  the  fasciculation’s
nd  the  mechanisms  proposed  ranges  from  impairing
elease  of  acetylcholine  by  morphine  and  narolphine,9
mpair  neurohumoral  transmission  at  peripheral  muscarinic
eceptors  by  morphine,9 blocking  the  prejunctional  recep-
ors  by  non  depolarizing  muscle  relaxants,3 motor  nerve
embrane  stabilization  by  reduction  of  calcium  ions  by
iphenylhydantoin,10 inhibition  of  calcium  release  leading
o  decrease  in  acetylcholine  release  by  magnesium.6
The  mechanism  of  the  inhibitory  action  of  pregabalin
n  succinylcholine  induced  muscle  fasciculation  is  unclear.
ince  intracellular  calcium  accumulation  is  important  for
nhancing  the  speed  and  strength  of  the  fasciculation’s  and
he  contraction  of  the  intrafusal  muscle  ﬁbers,  the  effect
f  pregabalin  on  voltage-gated  calcium  channels  may  be  a
ossible  mechanism  of  decreasing  the  muscle  contractions
eading  to  fasciculation’s.14
Postoperative  myalgia  following  the  use  of  succinyl-
holine  is  a  common,  troublesome  clinical  problem.
uccinylcholine-induced  postoperative  myalgia  is  most
requent  on  the  ﬁrst  postoperative  day.  The  exact  patho-
hysiology  for  succinylcholine  induced  myalgia  is  not  clear.
arious  proposed  mechanisms  of  its  causation  include
ncreased  myoplasmic  calcium  concentrations,  membrane
hospholipids  degradation,  released  free  fatty  acids,  and
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Table  4  Postoperative  sedation  score  (Ramsay  sedation  score)  and  fentanyl  consumption  within  24  h  after  surgery.
Group  C  (n  =  30)  Group  P  (n  =  31)  p-Value
Fentanyl  requirements  (mcg)  1002.67  ±  214.43  674.03  ±  137.84  <0.0001
Sedation score  2.27  ±  0.66  2.71  ±  0.69  0.0048
s
f
C
T
R
1
1
1
1
1Data are presented as mean values ± SD.
free  radicals  responsible  for  muscle  damage  leading  to  post-
operative  myalgia.15--18 Various  drugs  have  been  utilized  to
look  into  blocking  these  speciﬁc  targets  to  decrease  myalgia.
Pregabalin  inhibits  Ca2+ currents  via  high-voltage-
activated  channels  containing  the  2  subunit,19 reducing
neurotransmitter  release  (e.g.  glutamate,  substance  P,
calcitonin,  noradrenaline,  gene-related  peptide)  and  atten-
uating  the  postsynaptic  excitability,14 providing  the  basis
for  its  antinociceptive  efﬁcacy  in  post-operative  pain.20,21
The  above  facts  may  also  be  a  plausible  explanation  for  its
efﬁcacy  in  reducing  succinylcholine  induced  myalgia.
We  utilized  pregabalin  over  gabapentin  to  assess  its
effect  on  fasciculation  and  myalgia  as  pregabalin  has  higher
bioavailability  (90%  vs.  33--66%),  rapid  absorption  (with  peak
plasma  levels  at:  1  h  vs.  3--4  h)  and  a  linear  increase  in
plasma  concentration  as  its  dose  is  increased.  Lower  doses
of  pregabalin  than  that  of  gabapentin  (2--4-fold  lower  doses)
have  a  similar  analgesic  effect  on  neuropathic  pain,  which
makes  pregabalin  more  advantageous  in  terms  of  the  side
effects  of  dosage.22
Use  of  induction  agents  like  thiopentone  or  propofol  have
been  demonstrated  to  have  no  bearing  on  succinylcholine
induced  fasciculation  though  less  myalgia  is  seen  when
thiopentone  is  used  in  comparison  to  propofol.15 Maddineni
et  al.23 observed  that  there  is  no  difference  in  postoperative
myalgia  when  propofol  was  substituted  for  thiopentone  but
according  to  McClymont,24 propofol  is  better  than  thiopen-
tone  to  control  myalgia.
Our  study  is  in  agreement  with  various  studies  of
reduction  of  postoperative  pain  as  well  as  opioids  require-
ments  with  the  use  of  preoperative  pregabalin.  Reuben  and
colleagues25 observed  that  use  of  preoperative  pregabalin  in
patients  undergoing  lumbar  laminectomy  was  as  effective
as  celecoxib  in  reducing  postoperative  pain  and  patient-
controlled  morphine  consumption.  Agarwal  et  al.  reported
effectiveness  of  the  single  preoperative  oral  dose  of  150  mg
pregabalin  in  reducing  postoperative  pain  and  fentanyl  con-
sumption  in  laparoscopic  cholecystectomy.26
There  are  some  limitations  with  this  study:  (a)  the  study
design  was  observational,  and  we  measure  a  subjective  vari-
able  (fasciculation)  rather  than  objective  variables  (increase
in  potassium,  myoglobin,  and  CPK)  and  (b)  this  is  a  single
institutional  study  and  our  results  may  not  be  generalized.
Further  studies  in  different  settings  and  group  of  patients
may  give  a  better  understanding  of  use  of  pregabalin.
ConclusionOur  study  demonstrated  that  the  preoperative  adminis-
tration  of  150  mg  pregabalin  signiﬁcantly  decreased  the
severity  of  muscle  fasciculation’s,  without  an  effect  on  its
incidence.  It  also  decreased  the  incidence  and  severity  of
1uccinylcholine-induced  myalgia  as  well  as  postoperative
entanyl  consumption.
onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
eferences
1. Perry JJ, Lee JS, Sillberg VA, et al. Rocuronium versus suc-
cinylcholine for rapid sequence induction intubation. Cochrane
Database Syst Rev. 2008;16:CD002788.
2. Farhat K, Pasha AK, Jaffery N. Biochemical changes following
succinylcholine administration after pretreatment with rocuro-
nium at different intervals. J Pak Med Assoc. 2014;64:146--50.
3. True CA, Carter PJ. A comparison of tubocurarine, rocuro-
nium, and cisatracurium in the prevention and reduction
of succinylcholine-induced muscle fasciculations. AANA J.
2003;71:23--8.
4. Hassani M, Sahraian MA. Lidocaine or diazepam can decrease
fasciculation induced by succinylcholine during induction of
anesthesia. Middle East J Anesthesiol. 2006;18:929--31.
5. Shrivastava OP, Chatterji S, Kachhawa S, et al. Calcium glu-
conate pretreatment for prevention of succinylcholine-induced
myalgia. Anesth Analg. 1983;62:59--62.
6. Kumar M, Talwar N, Goyal R, et al. Effect of magnesium sulfate
with propofol induction of anesthesia on succinylcholine-
induced fasciculations and myalgia. J Anaesthesiol Clin
Pharmacol. 2012;28:81--5.
7. Rahimi M, Makarem J, Goharrizi AG. Succinylcholine-induced
myalgia in obstetric patients scheduled for caesarean section
-- diclofenac vs placebo patches. Middle East J Anesthesiol.
2009;20:417--22.
8. Celebi N, Canbay O, Cil H, et al. Effects of dexmedetomidine
on succinylcholine-induced myalgia in the early postoperative
period. Saudi Med J. 2013;34:369--73.
9. Yun MJ, Kim YH, Go YK, et al. Remifentanil attenuates muscle
fasciculations by succinylcholine. Yonsei Med J. 2010;51:585--9.
0. Hatta V, Saxena A, Kaul HL. Phenytoin reduces suxamethonium-
induced myalgia. Anaesthesia. 1992;47:664--7.
1. Leeson-Payne CG, Nicoll JM, Hobbs GJ. Use of ketorolac
in the prevention of suxamethonium myalgia. Br J Anaesth.
1994;73:788--90.
2. Pandey CK, Tripathi M, Joshi G, et al. Prophylactic use
of gabapentin for prevention of succinylcholine-induced
fasciculation and myalgia: a randomized, double-blinded,
placebo-controlled study. J Postgrad Med. 2012;58:19--22.
3. Hartman GS, Fiamengo SA, Riker WF Jr. Mechanism of
fasciculations and their prevention by d-tubocurarine or
diphenylhydantoin. Anesthesiology. 1986;65:405--13.
4. Fink K, Dooley DJ, Meder WP, et al. Inhibition of neuronal Ca(2+)
inﬂux by gabapentin and pregabalin in the human neocortex.
Neuropharmacology. 2002;42:229--36.
5. Schreiber JU, Lysakowski C, Fuchs-Buder T, et al. Prevention
of succinylcholine-induced fasciculation and myalgia: a meta-
analysis of randomized trials. Anesthesiology. 2005;103:877--84.
11
1
1
1
2
2
2
2
2
270  
6. McLoughlin C, Elliott P, McCarthy G, et al. Muscle pains and
biochemical changes following suxamethonium administration
after six pretreatment regimens. Anaesthesia. 1992;47:202--6.
7. Wong SF, Chung F. Succinylcholine-associated postoperative
myalgia. Anaesthesia. 2000;55:144--52.
8. Allen DG. Skeletal muscle function: role of ionic changes
in fatigue, damage and disease. Clin Exp Pharmacol Physiol.
2004;31:485--93.
9. Bauer CS, Rahman W,  Tran-van-Minh A, et al. The anti-allodynic
alpha(2)delta ligand pregabalin inhibits the trafﬁcking of the
calcium channel alpha(2)delta-1 subunit to presynaptic termi-
nals in vivo. Biochem Soc Trans. 2010;38:525--8.
0. Kavoussi R. Pregabalin: from molecule to medicine. Eur Neu-
ropsychopharmacol. 2006;16:S128--33.1. Clarke H, Bonin RP, Orser BA, et al. The prevention of chronic
postsurgical pain using gabapentin and pregabalin: a com-
bined systematic review and meta-analysis. Anesth Analg.
2012;115:428--42.
2V.K.  Srivastava  et  al.
2. Dauri M, Faria S, Gatti A, et al. Gabapentin and pre-
gabalin for the acute post-operative pain management. A
systematic--narrative review of the recent clinical evidences.
Curr Drug Targets. 2009;10:716--33.
3. Maddineni VR, Mirakhur RK, Cooper AR. Myalgia and biochemical
changes following suxamethonium after induction of anaes-
thesia with thiopentone or propofol. Anaesthesia. 1993;48:
626--8.
4. McClymont C. A comparison of the effect of propofol or thiopen-
tone on the incidence and severity of suxamethonium-induced
myalgia. Anaesth Intensive Care. 1994;22:147--9.
5. Reuben SS, Buvanendran A, Kroin JS, et al. The analgesic efﬁ-
cacy of celecoxib, pregabalin, and their combination for spinal
fusion surgery. Anesth Analg. 2006;103:1271--7.6. Agarwal A, Gautam S, Gupta D, et al. Evaluation of a single
preoperative dose of pregabalin for attenuation of postopera-
tive pain after laparoscopic cholecystectomy. Br J Anaesth.
2008;101:700--4.
